EU Approves Roche's Polivy Combination For Previously Untreated Diffuse Large B-cell Lymphoma

SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) said that the European Commission has granted approval of Polivy or polatuzumab vedotin in combination with MabThera or rituximab plus cyclophosphamide

Related Keywords

,European Union ,European Commission ,Approves ,Oche ,Polivy ,Combination ,Reviously ,Untreated ,Diffuse ,Barge ,Fell ,Lymphoma ,